Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]

1084 reported adverse events

Drugs of this class: LETERMOVIR

These side effects are most commonly reported by patients taking drugs of the Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] class:

# Side effect Count
0 OFF LABEL USE 213
1 CYTOMEGALOVIRUS INFECTION 87
2 DEATH 71
3 CYTOMEGALOVIRUS INFECTION REACTIVATION 65
4 DRUG INEFFECTIVE 65
5 DRUG INTERACTION 60
6 PATHOGEN RESISTANCE 55
7 PRODUCT USE IN UNAPPROVED INDICATION 50
8 CYTOMEGALOVIRUS VIRAEMIA 41
9 DRUG RESISTANCE 40
See all common reactions for Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]

Drugs of the Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 STENOTROPHOMONAS BACTERAEMIA 1 0.1667
1 CYTOMEGALOVIRUS TEST NEGATIVE 1 0.1667
2 HEPATIC HYPERTROPHY 2 0.1333
3 CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION 1 0.1250
4 VIRAL TITRE INCREASED 1 0.0833
5 GASTROINTESTINAL MUCORMYCOSIS 5 0.0769
6 GLUTAMATE DEHYDROGENASE LEVEL ABNORMAL 1 0.0714
7 FLUORIDE INCREASED 3 0.0638
8 OESOPHAGEAL MUCOSAL DISSECTION 2 0.0625
9 ADENOVIRUS REACTIVATION 3 0.0556
See all enriched reactions for Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]